Starch Or Derivative Patents (Class 514/778)
  • Patent number: 5688521
    Abstract: Object of the invention is a single dose form of application for lactulose in the form of pastilles based on at least partially or completely water soluble natural and/or synthetic polymers selected from gums, alginates, carrageen, starch, pectin, and gelatin comprising lactulose as active substance, as well as a process to prepare the said pastilles.
    Type: Grant
    Filed: December 1, 1995
    Date of Patent: November 18, 1997
    Assignee: Bolder Arzneimittel GmbH
    Inventors: Hermann-Josef Bolder, Faruk Imer
  • Patent number: 5688522
    Abstract: Wound healing compositions comprise from 1 to 20% by weight of a gel forming polysaccharide such as carboxymethyl cellulose and from 15 to 50% by weight of hexylene glycol. Such compositions are strongly antimicrobial, but show low toxicity to fibroblasts.
    Type: Grant
    Filed: August 13, 1996
    Date of Patent: November 18, 1997
    Assignee: Johnson & Johnson Medical, Inc.
    Inventor: Craig J. Hardy
  • Patent number: 5686385
    Abstract: The present invention provides microcapsule comprising agricultural active ingredients with improved physical properties, and an agricultural composition comprising said microcapsule. An agricultural microcapsule having a diameter of not more than 50 .mu.m comprises an agricultural active ingredient in a water-soluble coating material. As an agricultural composition comprising said microcapsules, DL dust, solidified emulsifiable concentrate can be provided.According to the present invention, the agricultural active ingredient is stabilized, agricultural dust can be mixed with even incompatible, liquid agricultural active ingredient, and agricultural microcapsule has excellent handling properties.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 11, 1997
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Kanji Akashi, Chikara Tanabayashi, Kazutaka Kitagawa
  • Patent number: 5684051
    Abstract: Elastically deformable medical devices, such as stents, having improved speed and degree of shape recovery are made by treating shaped hydrogels containing a polymer with a solution containing at least one elasticity agent, which may be nonionic or ionic. For example, polysaccharide-based hydrogels, such as barium alginate, are formed into tubing, shaped into pigtail stents, and exposed to an aqueous solution containing an elasticity agent such as potassium ions, sodium ions, sorbitol, glucose, citric acid, mannitol, dulcitol, or glycerol. The solution may also contain a crosslinking agent, such as calcium ions, to achieve the desired degree of elasticity.
    Type: Grant
    Filed: April 24, 1996
    Date of Patent: November 4, 1997
    Assignee: Hercules Incorporated
    Inventor: Samuel Anthony Thompson
  • Patent number: 5672356
    Abstract: Bioadhesive pharmaceutical composition for the controlled release of active principles locally across the buccal cavity or systemically across a mucous membrane, wherein it is composed of an active principle, a compound (A), a compound (B) and excipients as defined in the description.
    Type: Grant
    Filed: September 21, 1994
    Date of Patent: September 30, 1997
    Assignee: Adir et Compagnie
    Inventors: Isabelle Rault, Gerald Pichon, Alain Cuine
  • Patent number: 5670158
    Abstract: The subject invention involves pharmaceutical compositions in dosage unit form, for peroral administration of bisacodyl to a human or lower animal having a gastrointestinal tract, with a lumen therethrough, with a small intestine and a colon with a junction therebetween, comprising:(a) a safe and effective amount of rapidly-dissolving bisacodyl means; and(b) a delivery means which prevents the release of bisacodyl from the dosage form into the lumen of the gastrointestinal tract during transport of the dosage form through the lumen until the dosage form is near the junction between the small intestine and the colon or in the colon, and which then releases the bisacodyl in the lumen near the junction between the small intestine and the colon or within the colon,The subject invention also involves methods for providing laxation for humans and lower animals in need thereof by peroral administration of such compositions.
    Type: Grant
    Filed: November 15, 1995
    Date of Patent: September 23, 1997
    Assignee: The Procter & Gamble Company
    Inventors: Paula Denise Davis, Douglas Joseph Dobrozsi, Gary Robert Kelm, Kenneth Gary Mandel
  • Patent number: 5667803
    Abstract: The present invention is related to a novel type of composition with modifiable properties and suitable for controlled release of active ingredients in industrial use. The composition contains an active ingredient and starch acetate in the form of a compact. More specifically the invention relates to active ingredients such as solid dosage forms of drugs, especially compacts and tablets. In these compacts starch acetate with distinct substitution degrees are used. The starch acetate makes the process industrially feasible with good flowability and facilitates the formation of firm tablets. Starch acetate enables the controlled release of the active ingredient. The invention also discloses method for the preparation of the composition as well as its use.
    Type: Grant
    Filed: January 19, 1995
    Date of Patent: September 16, 1997
    Assignee: Oy Polymer Corex Kuopio Ltd.
    Inventors: Timo Petteri Paronen, Soili Hellevi Peltonen, Arto Olavi Urtti, Leena Johanna Nakari
  • Patent number: 5667801
    Abstract: A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. In certain embodiments, the sustained release excipient is granulated with a solution or suspension of a hydrophobic polymer in an amount effective to slow the hydration of the gelling agent when the formulation is exposed to an environmental fluid. In another embodiment, the tablet is coated with a hydrophobic polymer.
    Type: Grant
    Filed: May 21, 1996
    Date of Patent: September 16, 1997
    Assignee: Edward Mendell Co., Inc.
    Inventor: Anand R. Baichwal
  • Patent number: 5662933
    Abstract: A sustained release pharmaceutical formulation and methods of making and using the same are provided. The sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional hydrophobic material and/or hydrophobic coating, and a medicament for sustained oral administration.
    Type: Grant
    Filed: November 3, 1995
    Date of Patent: September 2, 1997
    Assignee: Edward Mendell Co., Inc.
    Inventors: Anand Baichwal, Troy W. McCall
  • Patent number: 5662937
    Abstract: A long life deodorant composition lasting up to about 7 days for foot odor, and up to about 15 days underarm, includes specially treated cornstarch or oat starch as a substitute for talc. Additionally the treated starch acts as a spreading agent, giving a silky smooth effect. Citric acid, an increased proportion of zinc oxide and aloe vera concentrate are advantageously included in the deodorant.
    Type: Grant
    Filed: August 17, 1995
    Date of Patent: September 2, 1997
    Inventor: Dorothy McCuaig
  • Patent number: 5658895
    Abstract: The invention provides an anticancer enteral feeding composition characterized by containing the described assortment of amino acids, fat and carbohydrate.This anticancer enteral feeding composition can be smoothly administered orally or via a tube to achieve alimentation of cancer patients and inhibition of growth of tumor cells in the patients. Moreover, as used in combination with an anticancer chemotherapeutic agent, it synergistically potentiates the antitumor efficacy of the latter agent.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 19, 1997
    Assignee: Otsuka Pharmaceutical Factory, Inc.
    Inventors: Shozo Aoi, Goro Ebisu
  • Patent number: 5656292
    Abstract: The present invention is related to a composition for pH dependent or pH regulated controlled release of active ingredients especially drugs. The composition consists of a compactible mixture of the active ingredient and starch molecules substituted with acetate and dicarboxylate residues. The preferred dicarboxylate acid is succinate. The average substitution degree of the acetate residue is at least 1 and 0.2-1.2 for the dicarboxylate residue. The starch molecules can have the acetate and dicarboxylate residues attached to the same starch molecule backbone or attached to separate starch molecule backbones. The present invention also discloses methods for preparing said starch acetate dicarboxylates by transesterification or mixing of starch acetates and starch dicarboxylates respectively.
    Type: Grant
    Filed: July 5, 1995
    Date of Patent: August 12, 1997
    Assignee: Alko Group Ltd.
    Inventors: Arto Olavi Urtti, Soili Hellevi Peltonen, Timo Petteri Paronen, Leena Johanna Nakari, Jani-Emanuel Vuorenpaa
  • Patent number: 5651983
    Abstract: The present invention relates to a pharmaceutical composition in a unit dosage form for peroral administration in a human or lower animal, having a gastrointestinal tract comprising a small intestine and a colon with a lumen therethrough having an inlet to the colon from the small intestine, comprising:a. a safe and effective amount of rapidly dissolving bisacodyl incorporated into or coated on the surface of a dosage form selected from the group consisting of a spherical substrate, an elliptical substrate, a hard capsule, or a compressed tablet, with a maximum diameter of about 3 mm to about 10 mm; andb. an enteric polymer coating material;wherein the dosage form has a smooth surface free from edges or sharp curves; the elliptical substrate and the hard capsule have a ratio of the long to short diameters of no greater than about 1.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: July 29, 1997
    Assignee: The Procter & Gamble Company
    Inventors: Gary Robert Kelm, Gary Lee Manring, Paula Denise Davis, Douglas Joseph Dobrozsi, Kenneth Gary Mandel, David Lee McCauley-Meyers
  • Patent number: 5648390
    Abstract: A method has been discovered for repelling ants by treating objects or areas with effective amounts of compositions that include (a) one or more C.sub.6 to C.sub.8 carboxylic acids; (b) one or more C.sub.6 to C.sub.14 alcohols; (c) one or more esters which are reaction products of (a) and (b) or an ester which is a reaction product of the repellents and other carboxylic acids or alcohols; (d) one or more C.sub.6 to C.sub.11 carboxylic acid esters; (e) one or more C.sub.6 to C.sub.14 ketones; or (f) mixtures thereof.
    Type: Grant
    Filed: August 4, 1994
    Date of Patent: July 15, 1997
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Robert K. Vander Meer, William A. Banks, Clifford S. Lofgren
  • Patent number: 5643603
    Abstract: A composition of a bioadhesive carrier for a prolonged, sustained and controlled delivery of a drug having a local or systemic action contains pregelatinized or thermally modified, food accepted starches and optionally a synthetic polymer.The pregelatinized starches are preferably precooked and dried starches.
    Type: Grant
    Filed: July 13, 1994
    Date of Patent: July 1, 1997
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Peter Bottenberg, Jean Paul Louis August Remon, Christian Dominique Erwin De Muynck, Dick Slop
  • Patent number: 5639468
    Abstract: Compositions and methods for minimizing or preventing post-surgical adhesion formation between tissue, e.g., organ, surfaces in body cavities, whereby an effective therapeutic amount of manoalide or analog thereof is administered to the target injury site for a period of time sufficient to permit tissue repair. Manoalide or analog thereof is preferably administered in conjunction with a delivery vehicle (e.g., microcapsules, microspheres, biodegradable polymer films, lipid-based delivery systems such as liposomes and lipid foams, crystalloid and viscous instillates and absorbable mechanical barriers) useful for maintaining local concentrations of the inhibitor at the injury site at an effective level for a sustained period of time.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 17, 1997
    Assignee: University of Southern California
    Inventors: Kathleen Elizabeth Rodgers, Gere Stodder diZerega
  • Patent number: 5631013
    Abstract: This invention provides cosmetic stick, roll-on and cream deodorant and deodorant-antiperspirant products. The cosmetic products consisting of an organic matrix having a dispersed phase of encapsulated particles of a co-micronized crystallite blend of inorganic compounds such as sodium bicarbonate and zinc oxide. The particle surfaces are coated with a polymer such as maltodextrin starch. When this type of cosmetic product is applied to underarm surfaces, a sustained deodorant activity by the encapsulated particles is obtained.
    Type: Grant
    Filed: August 7, 1995
    Date of Patent: May 20, 1997
    Assignee: Church & Dwight Co., Inc.
    Inventors: Wolfgang R. Bergmann, Richard T. Murphy
  • Patent number: 5629018
    Abstract: In a composition for delayed release of an active substance, the active substance is incorporated in a polysaccharide matrix which consists of an essentially crystalline straight-chain glucan and contains a glucan-degrading agent. The glucan is in particular an .alpha.-glucan which has essentially a helix structure. The glucan-degrading agent is preferably .alpha.-amylase. The composition can contain high-molecular materials such as proteins, allergens, vaccine substances and microorganisms, and preferably has the form of compressed tablets.
    Type: Grant
    Filed: February 15, 1995
    Date of Patent: May 13, 1997
    Assignee: Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek TNO
    Inventors: Arie C. Besemer, Jan P. Van Der Lugt
  • Patent number: 5629350
    Abstract: Stable, concentrated aqueous suspensions of ortho-phenylphenol (OPP) which contribute minimal chemical oxygen demand and methods of preparing and using said suspensions in biocidal applications have been discovered. The formulations comprise from about 3 to about 70 weight percent of OPP suspended in about 30 to about 97 weight percent water in the presence of a suspending amount of a thixotrope that exhibits Ellis-Plastic behavior.
    Type: Grant
    Filed: March 20, 1996
    Date of Patent: May 13, 1997
    Assignee: The Dow Chemical Company
    Inventor: Charles D. Gartner
  • Patent number: 5626878
    Abstract: A medicament adsorbate containing corn syrup having contained therein from about 10 to about 90% by weight of the adsorbate of a medicament drug a magnesium trisilicate having a surface area of at least 400 m.sup.2 /g and having a structure with multiple interstitial spaces, and having adsorbed therein from about 0.5 to about 30% by weight of the adsorbate of a medicament drug, wherein the medicament drug is an antihistamine. A reduction in the electrostatic forces between adsorbates is experienced due to the particle size of the adsorbate being in the range greater than 40 to about 800 um, most of the adsorbates prepared being a particle size greater than 150 um, which allows for better processing.
    Type: Grant
    Filed: January 10, 1995
    Date of Patent: May 6, 1997
    Assignee: Warner Lambert Company
    Inventors: Felipe Garay, Stanley Lech, Mark Oehling
  • Patent number: 5624683
    Abstract: A sustained-release multi-granule tablet is obtained by compressing sustained-release granules, which contains a basis, and a formulation adjuvant. Each of the granules has been coated in advance with a layer of the formulation adjuvant and/or a layer of a mixture of the formulation adjuvant and the basis. The tablet releases an active substance at a suitable velocity into the digestion tract, resulting in that the inbalance in the absorption of the drug in each patient and among individual patients is minimized to achieve maximum bioavailability.
    Type: Grant
    Filed: February 7, 1994
    Date of Patent: April 29, 1997
    Assignee: Eisai Co., Ltd.
    Inventors: Hidenobu Andoh, Sumio Watanabe, Yasuo Miyake
  • Patent number: 5624677
    Abstract: A composition providing a relatively slow release of water-soluble drugs, such as apomorphine, for delivery via the sublingual or buccal routes.
    Type: Grant
    Filed: June 13, 1995
    Date of Patent: April 29, 1997
    Assignee: Pentech Pharmaceuticals, Inc.
    Inventors: Ragab El-Rashidy, Bruce Ronsen, Emad E. Hassan
  • Patent number: 5618850
    Abstract: A method for alleviating the symptoms of a cosmetic or dermatologic skin condition is described. An effective amount of a poly(hydroxy acid)/polymer conjugate in a pharmaceutically or cosmetically acceptable vehicle is provided. Topical compositions of the conjugates with another cosmetic or dermatological agent, and compounds of the conjugates having attached physiologically active functional groups, are also provided.
    Type: Grant
    Filed: March 9, 1995
    Date of Patent: April 8, 1997
    Assignee: Focal, Inc.
    Inventors: Arthur J. Coury, Luis Z. Avila, Chandrashekhar P. Pathak, Shikha P. Barman
  • Patent number: 5616324
    Abstract: A synergistic mixture particularly suitable for the treatment of animals whic consists of at least two of the group consisting of DL.Phenylalanine, Ruta Graveolans and Corydali Bulbosa together with a carrier to make up a required volume, the mixture having a pro-inflammatory effect which accelerates the healing process of inflammation. It is preferred that there is provided mixture of DL.Phenylalanine with one product selected from the group of Ruta Graveolans and Corydalis Bulbosa. In a specific form, the mixture also includes Nicotinic Acid.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: April 1, 1997
    Inventors: Antoinette Foster, Don Foster
  • Patent number: 5614217
    Abstract: A gelatin capsule that is generally resistant to humidity having a non-hygroscopic plasticizer and an elasticity reducing gelatin extender in the formulation of the gelatin capsule shell. The capsule is capable of being manufactured on conventional rotary die encapsulation devices and can readily hold liquid fill materials. The capsule is breakable with manual pressure.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 25, 1997
    Assignee: R.P. Scherer Corporation
    Inventors: Timothy B. Chiprich, Michael T. Hoylman, Norman S. Stroud
  • Patent number: 5595762
    Abstract: Stabilized pulverulent active agents, compositions containing them and also process for obtaining them; such stabilized active agents enable dry and stable pharmaceutical, dietary, nutritional or cosmetic compositions to be obtained, in which the properties of the said active agents are neither modified nor impaired. Such stabilized active agents are stabilized by coating with a coating composition comprising:-- at least one film-forming agent, in proportions of between 2 and 25% by weight of the final mass, selected from polyvinylpyrrolidones (povidone), polyvinyl alcohols, vinylpyrrolidone/vinyl acetate copolymer, vinylpyrrolidone/polyvinyl alcohol copolymer, cellulose derivatives such as cellulose acetate, cellulose acetate phthalate, cellulose butyrate, ethylcellulose and methylcellulose, acrylic and methacrylic polymers and copolymers and vegetable, animal or synthetic waxes, and-- at least one pore-forming agent, in proportions of between 0 and 5%, by weight preferably of between 0.
    Type: Grant
    Filed: November 30, 1993
    Date of Patent: January 21, 1997
    Assignee: Laboratoires Virbac
    Inventors: Guy Derrieu, Bernard Raynier
  • Patent number: 5591611
    Abstract: Disclosed is a trehalose-releasing enzyme which specifically hydrolyzes the linkage between a trehalose moiety and the remaining glycosyl moiety in a non-reducing saccharide having a trehalose structure as an end unit and having a degree of glucose polymerization of 3 or higher. The molecular weight of the enzyme is about 57,000 to 68,000 daltons on SDS-PAGE, and the isoelectric point is about 3.3 to 4.6 on isoelectrophoresis. The enzyme is useful in an industrial-scale preparation of trehalose, and the trehalose prepared therewith can be readily incorporated into food products, as well as cosmetic- and pharmaceutical-compositions.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 7, 1997
    Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Kazuhiko Maruta, Michio Kubota, Toshiyuki Sugimoto, Toshio Miyake
  • Patent number: 5565407
    Abstract: Improved release-extending compositions are provided for encapsulation of bioactive agents which exhibit reduced release rates of the bioactive agent from the composition matrix when compared with conventional encapsulated formulations, most preferably employed in agricultural applications for insect and weed control. The compositions of the invention from about 25-75 wt. % (non-active ingredient basis) native, undenatured starch, from about 25-75 wt. % (non-active ingredient basis) biodegradable synthetic polymer, and from about 1-40 wt. % bioactive agent.
    Type: Grant
    Filed: December 19, 1994
    Date of Patent: October 15, 1996
    Assignee: University of Kansas Center for Research, Inc.
    Inventor: Marylee Z. Southard
  • Patent number: 5554577
    Abstract: The subject matter comprises shaped mixtures of valuable materials for the stimulation and cultivation of plant growth, said materials containing plant nutrients and/or plant-protective agents in admixture with a thermoplastic binder. According to the invention the mixtures of valuable materials, which mixtures have in particular been shaped as fertilizer rods, are characterized in that they contain, as the binder, a starch that has been thermomechanically digested at elevated pressures and temperatures.The invention further relates to the process for producing these multi-component mixtures and to the use of thermomechanically digested starch, optionally in admixture with inferior amounts of further biologically compatible binder components, as a biologically degradable binder for mixtures of valuable materials of the type described.
    Type: Grant
    Filed: October 13, 1994
    Date of Patent: September 10, 1996
    Assignee: Henkel Kommanditgesellschaft auf Aktien
    Inventors: Wolfgang Kempf, Peter Schroeder, Wolfgang Ritter, Bernd Ebbe
  • Patent number: 5554388
    Abstract: A composition for administration to the mucosa comprises a pharmacologically active compound and a polycationic substance. The polycationic substance is preferably DEAE-dextran or chitosan and the pharmacologically active compound is preferably insulin or calcitonin. The composition may be a solution, dispersion, powder or microspheres. Other enhancers, such as lysophosphatidylcholine, can be included if desired.
    Type: Grant
    Filed: December 14, 1993
    Date of Patent: September 10, 1996
    Assignee: Danbiosyst UK Limited
    Inventor: Lisbeth Illum
  • Patent number: 5540930
    Abstract: The invention provides novel compositions of matter containing water-insoluble steroid drugs suitable for therapeutic use. The invention provides stable aqueous suspensions of water-insoluble steroid drugs of particle sizes of .ltoreq.15 .mu.m which remain in such a state so as to allow for immediate suspension, when desired, even after extended periods of settling.
    Type: Grant
    Filed: October 25, 1993
    Date of Patent: July 30, 1996
    Assignee: Pharmos Corporation
    Inventors: Yaacov J. Guy, Doron I. Friedman
  • Patent number: 5534262
    Abstract: A granulated composition for direct tableting, comprising non-pressed or difficulty pressed, water-soluble, crystalline pharmaceutical substances, binder, lubricant and water, contains at least 98 wt. % of a pharmaceutically active component. The tablets manufactured from said composition have high hardness and the controllable time of dissolution. A method for preparing said composition consists in that the powder of a pharmaceutical substance is pre-granulated with water or its aqueous solution, the resultant granulate is then subjected to subsequent granulation with a binder solution, dried and powdered with lubricant.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: July 9, 1996
    Inventors: Anatoly E. Dobrotvorsky, Yaroslav A. Rozputnyak, Galina N. Khuchua, Irina A. Komissarova
  • Patent number: 5518986
    Abstract: The present invention provides an effective method for controlling foliage and root fungus infection in cultivated crops. A fungicide composition in the form of an aqueous formulation which is applied to pre-harvest crops contains ingredients such as pentachloronitrobenzene, sodium bicarbonate, sodium carbonate, potassium oleate, potassium octanoate and xanthan gum. The combination of potassium oleate, potassium octanoate and xanthan gum functions as an effective spreader-sticker medium for forming an adherent coating on plant foliage surfaces, and for saturating ground soil. The coating exhibits both immediate and long duration fungicidal activities.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: May 21, 1996
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston
  • Patent number: 5518987
    Abstract: The present invention provides an effective method for controlling foliage and root fungus infection in cultivated crops. A fungicide composition in the form of an aqueous formulation which is applied to pre-harvest crops contains ingredients such as etridiazole, potassium bicarbonate, sodium carbonate, potassium oleate, potassium caprylate and xanthan gum. The combination of potassium oleate, potassium caprylate and xanthan gum functions as an effective spreader-sticker medium for forming an adherent coating on plant foliage surfaces, and for saturating ground soil. The coating exhibits both immediate and long duration fungicidal activities.
    Type: Grant
    Filed: October 3, 1995
    Date of Patent: May 21, 1996
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston
  • Patent number: 5519012
    Abstract: Novel inclusion complexes of racemic 1,4-dihydropyridines and enantiomers thereof of the formula ##STR1## wherein R represents a phenyl group, substituted with nitro, trifluoromethyl, difluoromethoxy group or with one or two halo atoms (especially chlorine),R.sub.1 and R.sub.2, if the same, represent methyl groups and if one of them has the meaning of a 2-aminoethoxymethyl or cyano group, the other represents a methyl group,R.sub.3 and R.sub.4, if different, stand each time for a hydrogen, linear or branched C.sub.1 -C.sub.6 -alkyl, 2-methoxyethyl, 1-(phenylmethyl)-3-piperidinylphenyl, styryl, furyl, piperidino, 4-diphenylmethyl-1-piperazinylethyl, 5-phenyl-3-pirazolyloxy, 1-phenyl-methyl-3-pyrrolidinyl group or a group of the formula ##STR2## or, if the same, stand each time C.sub.1 -C.sub.4 alkyl group, and of acid addition salts thereof with methyl-.beta.-cyclodextrin, hydroxy-ethyl-.beta.-cyclodextrin or hydroxypropyl-.beta.
    Type: Grant
    Filed: December 16, 1994
    Date of Patent: May 21, 1996
    Assignee: LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d., Ljubljana
    Inventors: Darja Fercej-Temeljotov, Janko Zmitek, Breda Husu-Kovacevic, Sonja Kotnik, Zdenka Jerala-Strukelj
  • Patent number: 5516747
    Abstract: Surfactant mixtures of an alkyl naphthalene sulfonate and an alkyl polyglycoside, wherein the alkyl polyglycoside is present in from 5 to 25% by weight of the surfactant mixture, and aqueous pesticide compositions containing the surfactant mixture.
    Type: Grant
    Filed: April 18, 1994
    Date of Patent: May 14, 1996
    Assignee: Henkel Corporation
    Inventor: Frank J. Lachut
  • Patent number: 5512298
    Abstract: The present invention relates to hard capsules of cytarabine ocfosfate which is useful as an anti-leukemia drug applicable to oral administration.By providing the cytarabine ocfosfate hard capsule comprising (1) cytarabine ocfosfate, (2) a high molecular compound functioning as a disintegrator and (3) an alkali, there can be provided pharmaceutical preparations having excellent disintegration property and stability. The cytarabine ocfosfate hard capsules are applicable to clinical use.
    Type: Grant
    Filed: March 24, 1993
    Date of Patent: April 30, 1996
    Assignee: Nippon Kayaku Kabushiki Kaisha
    Inventors: Minoru Aoki, Hiroshi Ohtaki, Nobuharu Fukui, Takashi Terada, Minoru Nakada, deceased
  • Patent number: 5496861
    Abstract: Emulsion-containing cosmetic compositions, wherein the emulsion comprises an aqueous dispersion of 15 to 40% solids, by weight, of an enzymatically degraded starch, which starch has been debranched by treatment with an alpha-1,6-D-glucanohydrolase to yield up to 100%, by weight, short chain amylose, are provided herein. Also provided are oil-free cosmetic compositions and cosmetic stick compositions, comprising 1 to 16% enzymatically debranched starch; 2 to 35% water; 35 to 90% hydrophobic base, selected from the group consisting of oil, wax and fat, and 5 to 20% emulsifier(s), with the balance of the compositions comprising one or more adjuncts selected from dye(s), fragrance(s), flavor(s), sunscreen agent(s), opacifier(s), and filler(s). Also provided is a method for formulating a cosmetic stick composition.
    Type: Grant
    Filed: January 24, 1994
    Date of Patent: March 5, 1996
    Assignee: National Starch and Chemical Investment Holding Corporation
    Inventors: William Rouse, 3, Maria Valles, Gary T. Martino, Chung-Wai Chiu
  • Patent number: 5496563
    Abstract: There is provided a dry gel composition comprising 40% by weight or below of a medicine which can be orally administered, 3% by weight or above of a gelling agent and 5% by weight or below of a binder, which composition is capable of forming a gruel-like aqueous gel composition upon mixing with 2 to 15 parts by weight of water per part by weight of the composition at a temperature of 40.degree. C. or below. The gelling agent usable herein is, for example, pregelatinized starch having a concentration of 50% by weight or above. The medicine which can be orally administered is, for example, cinnarizine. Upon mixing with a predetermined quantity of water, the dry gel composition forms a homogeneous aqueous gel composition having a viscosity of about 100 to 500 cp, which is preferably thixotropic. Even aged people having a weak swallowing function can easily swallow the aqueous gel composition, without causing improper sucking into their tracheas.
    Type: Grant
    Filed: February 28, 1994
    Date of Patent: March 5, 1996
    Assignee: Showa Yakuhin Kako Co., Ltd.
    Inventors: Yoji Ito, Yasuo Hirai
  • Patent number: 5496568
    Abstract: The present invention provides an effective method for controlling foliage and root fungus infection in cultivated crops. A fungicide composition in the form of an aqueous formulation which is applied to pre-harvest crops contains ingredients such as propiconazole, sodium bicarbonate, potassium bicarbonate, sodium oleate, sodium caprylate and xanthan gum. The combination of sodium oleate, sodium caprylate and xanthan gum functions as an effective spreader-sticker medium for forming an adherent coating on plant foliage surfaces, and for saturating ground soil. The coating exhibits both immediate and long duration fungicidal activities.
    Type: Grant
    Filed: June 26, 1995
    Date of Patent: March 5, 1996
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston
  • Patent number: 5486508
    Abstract: A pharmaceutical composition comprising a slightly water-soluble drug, a cyclodextrin and a water-soluble organic solvent is disclosed. The composition improves water-solubility and stability of the slightly water-soluble drug. The pharmaceutical composition is particularly suitable for injection preparations.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: January 23, 1996
    Assignee: TAKEDA Chemical Industries Ltd.
    Inventors: Yoshiaki Uda, Yoko Nishida, Yasuaki Ogawa
  • Patent number: 5484601
    Abstract: A flowable demineralized bone powder composition is provided for use in surgical bone repair.
    Type: Grant
    Filed: October 18, 1991
    Date of Patent: January 16, 1996
    Assignee: Osteotech, Inc.
    Inventors: Robert K. O'Leary, Patrick A. McBrayer
  • Patent number: 5468716
    Abstract: The present invention provides a fungicide composition which contains ingredients which are biocompatible for purposes of agricultural applications, and which are harmless to animals and humans. An invention fungicide composition in the form of a dry blend formulation remains non-caking and free-flowing under storage conditions. Illustrative of an invention fungicide composition is a formulation which has a content of sodium bicarbonate, potassium bicarbonate, xanthan gum, dialkylsulfosuccinate salt and alkyl sulfate salt surfactants, and magnesium silicate anti-caking ingredient. The xanthan gum and surfactants function as an effective spreader-sticker and film-forming medium when the composition is diluted with water for agricultural applications.
    Type: Grant
    Filed: October 3, 1994
    Date of Patent: November 21, 1995
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston
  • Patent number: 5466461
    Abstract: New polysaccharide esters are disclosed, and more precisely esters of acidic polysaccharides chosen from the group formed by carboxymethylcellulose, carboxymethyl starch and carboxymethylchitin. These new esters and some esters of the type already known are useful as medicaments, for the manufacture of pharmaceutical and cosmetic preparations, in the field of biodegradable plastic materials and, therefore, for the manufacture of medical, surgical and sanitary articles, as well as numerous other industrial sectors in the place of acidic polysaccharides now in common use.
    Type: Grant
    Filed: April 2, 1992
    Date of Patent: November 14, 1995
    Assignee: Fidia, S.p.A.
    Inventors: Francesco della Valle, Aurelio Romeo
  • Patent number: 5464805
    Abstract: The present invention provides a method for controlling mildew in cultivated crops. The aqueous fungicide formulation which is applied to pre-harvest and post-harvest crops contains ingredients which are biocompatible for purposes of agricultural and horticultural applications. Illustrative of a formulation which is harmless to animals and humans is an aqueous solution having a content of potassium bicarbonate, potassium carbonate, potassium oleate and xanthan gum. The combination of potassium oleate and xanthan gum functions as an effective spreader-sticker medium for forming a solid coating on plant surfaces. The solid coating exhibits both immediate and long duration fungicidal activities.
    Type: Grant
    Filed: March 23, 1995
    Date of Patent: November 7, 1995
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston
  • Patent number: 5456923
    Abstract: The object of this invention is to provide a process for producing a solid dispersion, which has overcome the disadvantages of the conventional production technology for solid dispersions. The invention comprises employing a twin-screw extruder in the production of a solid dispersion. In accordance with the invention, a solid dispersion can be expediently produced without heating a drug and a polymer to or beyond their melting points and without using an organic solvent for dissolving both components and the resulting solid dispersion has excellent performance characteristics.
    Type: Grant
    Filed: November 15, 1993
    Date of Patent: October 10, 1995
    Assignee: Nippon Shinyaku Company, Limited
    Inventors: Kouichi Nakamichi, Shogo Izumi, Hiroyuki Yasuura
  • Patent number: 5455046
    Abstract: A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. In certain embodiments, the sustained release excipient is granulated with a solution or suspension of a hydrophobic polymer in an amount effective to slow the hydration of the gelling agent when the formulation is exposed to an environmental fluid. In another embodiment, the tablet is coated with a hydrophobic polymer.
    Type: Grant
    Filed: September 9, 1993
    Date of Patent: October 3, 1995
    Assignee: Edward Mendell Co., Inc.
    Inventor: Anand R. Baichwal
  • Patent number: 5432146
    Abstract: The present invention provides a fungicidal fertilizer composition which contains ingredients which are biocompatible for purposes of agricultural applications, and which are harmless to animals and humans. An invention fungicide composition in the form of a dry blend formulation remains non-caking and free-flowing under storage conditions. Illustrative of an invention fungicide composition is a formulation which has a content of sodium bicarbonate, potassium bicarbonate, potassium oleate, xanthan gum and a fertilizer-effective content of nitrogen, phosphorus and potassium elements. The combination of potassium oleate and xanthan gum functions as an effective spreader-sticker and film-forming medium when the composition is diluted with water for agricultural applications. When the aqueous medium is hard water, calcium oleate is formed which enhances the sticker properties of the aqueous fungicide composition in agricultural applications.
    Type: Grant
    Filed: December 20, 1993
    Date of Patent: July 11, 1995
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston
  • Patent number: 5432148
    Abstract: This invention provides a fungicide composition which is capable of in situ generation of ammonium bicarbonate when applied to plant foliage in the form of an aqueous dispersion. The constituents include (1) an ingredient such as urea which slow-releases ammonia under aqueous alkaline pH conditions; and (2) an alkali metal bicarbonate ingredient which imparts alkalinity to the aqueous dispersion, and provides bicarbonate ions for combination with the released ammonium ions. A spreader-sticker ingredient is included to maintain the ingredients in contact with plant foliage over an extended period after application.
    Type: Grant
    Filed: December 7, 1994
    Date of Patent: July 11, 1995
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston
  • Patent number: 5425952
    Abstract: This invention provides a fungicide composition which is capable of in situ generation of ammonium bicarbonate when applied to plant foliage in the form of an aqueous dispersion. The constituents include (1) an ingredient such as urea which slow-releases ammonia under aqueous alkaline pH conditions; and (2) an alkali metal bicarbonate ingredient which imparts alkalinity to the aqueous dispersion, and provides bicarbonate ions for combination with the released ammonium ions. A spreader-sticker ingredient is included to maintain the ingredients in contact with plant foliage over an extended period after application.
    Type: Grant
    Filed: October 13, 1993
    Date of Patent: June 20, 1995
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston